Express Scripts Earns $1.90 per Share

After the closing bell, Express Scripts (ESRX) reported Q3 earnings of $1.90 per share. That was three cents better than expectations.

“We have taken significant steps forward this year to build upon our heritage of industry leadership, client alignment and quality patient care, all of which positions us for growth,” said Tim Wentworth, President and CEO of Express Scripts. “We are transforming Express Scripts to win for the long term through significant investments in technology, launches of novel solutions that address the country’s biggest healthcare challenges, and expanding our role and reach in the broader healthcare market with our agreement to acquire eviCore. Payers and patients want affordable, quality care and access to medicine. No one is better positioned than Express Scripts to put medicine within reach.

Here are some details for the last quarter:

Adjusted claims of 343.6 million, down 1%

GAAP net income of $841.7 million, up 16%

GAAP earnings per diluted share of $1.46, up 27%

Adjusted EBITDA of $1,947.4 million, flat from 2016 EBITDA

Adjusted EBITDA per adjusted claim of $5.67, up 1% from 2016 EBITDA per adjusted claim

Adjusted net income of $1,093.6 million, flat from 2016 adjusted net income

Adjusted earnings per diluted share of $1.90, up 9%

Net cash flow provided by operating activities of $1,899.9 million, up 28%

Now for guidance. Express raised its 2017 range from $6.95 – $7.05 per share to $6.97 – $7.05 per share. The midpoint represents 10% growth over last year. For Q4, Express expects $2.03 to $2.11 per share.

Posted by on October 24th, 2017 at 4:07 pm


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.